Patent Yard Sign in
Canadian application, no grantCanada

Human antibodies that bind human il-12 and methods for producing

CA 2669512 A1 · Owner: White, Michael · Inventors: Banerjee, Subhashis; White, Michael; Derbyshire, Elaine J.

CIPO record

Overview

Drawings and full text

Its claims, description and drawings are in the Canadian Patents Database.

Open the CIPO record

Abstract From the Canadian patent

Human antibodies, preferably recombinant human antibodies that specifically , bind to , human interleukin-12 (hIL-12) are disclosed. Preferred antibodies have high affinity for hIL-12 , and neutralize hIL-12 activity in vitro and in vivo. An antibody of the invention can be a , full--length antibody or an antigen-binding portion thereof. The antibodies or antibody portions, of , the inveniton are useful for detecting hIL-12 and for inhibiting hIL-12 activity, e.g. in a human , subject suffering from a disorder in which hIL-12 activity is detrimental. Nucleic acids, vectors , and host cells for expressing the recombinant human antibodies of the invention, and methods of , synthesizing …

Read the whole patent

Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.

Why it's free to use

  • Filed March 24, 2000. No grant is recorded for it in Canada; had it been granted, its 20-year term would have ended March 24, 2020.
  • A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by March 24, 2022.
  • We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
FiledMarch 24, 2000
GrantedNo grant recorded
Term endedMarch 24, 2020
Patent numberCA 2669512 A1
Classification (IPC)C07K16/24 +2 more

Timeline

Timeline From CIPO dates

2001200320052007200920112013201520172019Application filedMarch 24, 2000Term endedMarch 24, 2020

Sources & verification

Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.